CVE-2017-1651

Description

IBM Rational Quality Manager and IBM Rational Collaborative Lifecycle Management 5.0 through 5.0.2 and 6.0 through 6.0.5 are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 133261.

Category

5.4
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.18%
Third-Party Advisory ibmcloud.com Third-Party Advisory ibm.com
Affected: IBM Rational Quality Manager
Affected: IBM Rational Collaborative Lifecycle Management
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/133261 vdb entry third party advisory
https://www-prd-trops.events.ibm.com/node/715749 third party advisory broken link

Frequently Asked Questions

What is the severity of CVE-2017-1651?
CVE-2017-1651 has been scored as a medium severity vulnerability.
How to fix CVE-2017-1651?
To fix CVE-2017-1651, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-1651 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-1651 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-1651?
CVE-2017-1651 affects IBM Rational Quality Manager, IBM Rational Collaborative Lifecycle Management.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.